RU2017125963A - Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты - Google Patents

Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты Download PDF

Info

Publication number
RU2017125963A
RU2017125963A RU2017125963A RU2017125963A RU2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A RU 2017125963 A RU2017125963 A RU 2017125963A
Authority
RU
Russia
Prior art keywords
composition
lysine
polyunsaturated fatty
fatty acids
omega
Prior art date
Application number
RU2017125963A
Other languages
English (en)
Other versions
RU2017125963A3 (ru
RU2706072C2 (ru
Inventor
Гюнтер КНАУП
Милан ЛАТИНОВИЧ
Михаэль ШВАРМ
Original Assignee
Эвоник Дегусса Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344990&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2017125963(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Эвоник Дегусса Гмбх filed Critical Эвоник Дегусса Гмбх
Publication of RU2017125963A publication Critical patent/RU2017125963A/ru
Publication of RU2017125963A3 publication Critical patent/RU2017125963A3/ru
Application granted granted Critical
Publication of RU2706072C2 publication Critical patent/RU2706072C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021Preserving by using additives, e.g. anti-oxidants containing oxygen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • C11B5/0085Substances of natural origin of unknown constitution, f.i. plant extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/18Lipids
    • A23V2250/186Fatty acids
    • A23V2250/1882Polyunsaturated fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (11)

1. Способ повышения устойчивости к окислению композиции, содержащей омега-6 полиненасыщенные жирные кислоты, включающий следующие стадии:
(i) обеспечение исходной композиции, содержащей по меньшей мере один компонент, представляющий собой омега-6 полиненасыщенную жирную кислоту;
(ii) обеспечение композиции на основе лизина;
(iii) смешивание водных, водно-спиртовых или спиртовых растворов исходной композиции и композиции на основе лизина и затем подвергание полученной в результате смеси воздействию условий высушивания распылением с образованием, таким образом, композиции в виде твердого продукта, содержащей по меньшей мере одну соль, образованную катионом, полученным из лизина, и анионом, полученным из омега-6 полиненасыщенной жирной кислоты; при этом композиция в виде продукта характеризуется содержанием растворителя SC, выбранным из следующего: SC < 5 вес. %, SC < 3 вес. %, SC < 1 вес. %, SC < 0,5 вес. %.
2. Способ по п. 1, где композицию на основе лизина на стадии (ii) обеспечивают таким образом, что отношение R = n(ca)/n(lys) количества функциональных групп карбоновой кислоты n(ca) в исходной композиции, обеспеченной на стадии (i), к количеству лизина n(lys) в композиции на основе лизина, обеспеченной на стадии (ii), находится в диапазоне, выбранном из 0,9 < R < 1,1, 0,95 < R < 1,05, 0,98 < R < 1,02.
3. Способ по п. 2, где исходная композиция, обеспеченная на стадии (i), содержит не более x(fe) вес. % сложных эфиров жирных кислот, где x(fe) выбран из 5, 3, 2, 1, 0,3, 0.
4. Способ по п. 3, где исходную композицию на стадии (i) и композицию на основе лизина на стадии (ii) обеспечивают таким образом, что по меньшей мере sp вес. % композиции в виде продукта состоит из одной или более солей, образованных катионами, полученными из лизина, и анионами, полученными из одной или более омега-6 полиненасыщенных жирных кислот и других встречающихся в природе жирных кислот, при этом sp выбран из 90, 95, 97, 98, 99, 100.
5. Композиция, получаемая с помощью способа по любому из пп. 1-4.
6. Применение композиции по п. 5 для изготовления пищевых продуктов, содержащих омега-6 полиненасыщенные жирные кислоты.
7. Применение композиции по п. 5 для изготовления питательных продуктов, содержащих омега-6 полиненасыщенные жирные кислоты.
8. Применение композиции по п. 5 для изготовления фармацевтических продуктов, содержащих омега-6 полиненасыщенные жирные кислоты.
RU2017125963A 2014-12-23 2015-12-17 Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты RU2706072C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14199976 2014-12-23
EP14199976.3 2014-12-23
PCT/EP2015/080293 WO2016102316A1 (en) 2014-12-23 2015-12-17 Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids

Publications (3)

Publication Number Publication Date
RU2017125963A true RU2017125963A (ru) 2019-01-24
RU2017125963A3 RU2017125963A3 (ru) 2019-06-18
RU2706072C2 RU2706072C2 (ru) 2019-11-13

Family

ID=52344990

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017125963A RU2706072C2 (ru) 2014-12-23 2015-12-17 Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты

Country Status (25)

Country Link
US (1) US20170367394A1 (ru)
EP (1) EP3236783B1 (ru)
JP (1) JP6714000B2 (ru)
KR (1) KR20170094789A (ru)
CN (1) CN107105693B (ru)
AU (1) AU2015371457B2 (ru)
BR (1) BR112017013445B1 (ru)
CA (1) CA2969157C (ru)
CL (1) CL2017001613A1 (ru)
CO (1) CO2017005849A2 (ru)
DK (1) DK3236783T3 (ru)
ES (1) ES2776393T3 (ru)
IL (1) IL252482B (ru)
MX (1) MX2017008274A (ru)
MY (1) MY190506A (ru)
NZ (1) NZ732380A (ru)
PE (1) PE20171082A1 (ru)
PH (1) PH12017501144A1 (ru)
PL (1) PL3236783T3 (ru)
RU (1) RU2706072C2 (ru)
SA (1) SA517381762B1 (ru)
SG (1) SG11201704399RA (ru)
TW (1) TWI693893B (ru)
WO (1) WO2016102316A1 (ru)
ZA (1) ZA201704821B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018317802B2 (en) 2017-08-15 2024-04-04 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019093708A1 (ko) * 2017-11-08 2019-05-16 김승수 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
BR112022002129A2 (pt) * 2019-08-08 2022-04-19 Evonik Operations Gmbh Processo a jusante para a produção de sais de ácidos graxos poli-insaturados
WO2021023850A1 (en) 2019-08-08 2021-02-11 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
US20220287979A1 (en) 2019-08-08 2022-09-15 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
US20220287345A1 (en) 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
WO2021151199A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
US20230037453A1 (en) 2020-04-01 2023-02-09 Evonik Operations Gmbh Preparation for use as vasorelaxant
EP4125438A1 (en) 2020-04-01 2023-02-08 Evonik Operations GmbH Preparation for use as antioxidant
CN111635306B (zh) * 2020-06-12 2022-09-27 上海海益环保科技有限公司 一种芥酸复合稳定剂及制备稳定芥酸的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
CN100352889C (zh) * 2002-11-22 2007-12-05 日本水产株式会社 高氧化稳定性的含有双键有机物的组合物
JP4870430B2 (ja) * 2003-06-20 2012-02-08 持田製薬株式会社 下肢静脈瘤予防・治療用組成物
ES2337082T3 (es) * 2005-02-02 2010-04-20 Dsm Ip Assets B.V. Composiciones en polvo.
EP2573188A2 (en) * 2005-03-02 2013-03-27 Metanomics GmbH Process for the production of fine chemicals
CN107362154B (zh) * 2006-06-05 2020-10-30 帝斯曼营养品股份公司 具有改进壳层的微胶囊
EP2037746A4 (en) * 2006-06-29 2010-09-22 Martek Biosciences Corp GREATEST OIL COMPOSITIONS AND MANUFACTURING METHOD THEREFOR
US8975299B2 (en) * 2007-11-01 2015-03-10 Enzymotec Ltd. Lipid mixture for infant nutrition
CA2803558C (en) * 2010-06-30 2018-05-29 Mochida Pharmaceutical Co., Ltd. .omega.3 fatty acid compound preparation

Also Published As

Publication number Publication date
WO2016102316A1 (en) 2016-06-30
SA517381762B1 (ar) 2020-10-27
NZ732380A (en) 2024-03-22
IL252482B (en) 2021-08-31
BR112017013445A2 (pt) 2018-06-26
MY190506A (en) 2022-04-26
CL2017001613A1 (es) 2018-01-12
CN107105693A (zh) 2017-08-29
CA2969157A1 (en) 2016-06-30
SG11201704399RA (en) 2017-07-28
TW201639463A (zh) 2016-11-16
PL3236783T3 (pl) 2020-06-15
RU2017125963A3 (ru) 2019-06-18
US20170367394A1 (en) 2017-12-28
CA2969157C (en) 2024-05-28
MX2017008274A (es) 2017-10-02
ES2776393T3 (es) 2020-07-30
JP6714000B2 (ja) 2020-06-24
AU2015371457A1 (en) 2017-06-22
DK3236783T3 (da) 2020-04-27
CO2017005849A2 (es) 2017-09-20
BR112017013445B1 (pt) 2021-11-23
IL252482A0 (en) 2017-07-31
TWI693893B (zh) 2020-05-21
KR20170094789A (ko) 2017-08-21
AU2015371457B2 (en) 2020-04-23
EP3236783B1 (en) 2020-02-05
PH12017501144A1 (en) 2018-03-05
EP3236783A1 (en) 2017-11-01
CN107105693B (zh) 2021-04-02
RU2706072C2 (ru) 2019-11-13
ZA201704821B (en) 2019-06-26
JP2018501790A (ja) 2018-01-25
PE20171082A1 (es) 2017-08-03

Similar Documents

Publication Publication Date Title
RU2017125962A (ru) Способ повышения устойчивости композиции, содержащей омега-3 полиненасыщенные жирные кислоты
RU2017125963A (ru) Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты
JP2018526325A5 (ru)
RU2014118120A (ru) Привлекательный корм для домашних животных и способы улучшения привлекательности корма для домашних животных
CA3010992A1 (en) Treatment of surface-reacted calcium carbonate
WO2009102845A3 (en) Food products containing omega-3 fatty acids
HRP20211437T1 (hr) Pripravak insekticida/miticida na bazi soli masnih kiselina
WO2014011895A3 (en) High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof
WO2015011724A3 (en) A novel omega -3 fatty acid composition with a plant extract
WO2017171423A3 (ko) 갈릭산 함량이 증진된 연 캘러스 추출물, 이의 제조방법 및 이를 함유하는 미백용 화장료 조성물
WO2016137825A8 (en) Millicapsule formulations comprising polyunsaturated free fatty acids
MX2018007610A (es) Composiciones activas suavizantes de tejidos.
WO2012112841A3 (en) [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation
JP2015506175A (ja) Dhaおよびepaを含む有機エマルション
ATE549943T1 (de) Verfahren zur herstellung von sojasaucenpulver
EA201890018A1 (ru) Композиция для придания формы волосам
WO2015013678A3 (en) Stable fatty acid compositions
RU2017137141A (ru) Жидкие концентраты для производства напитков, стабилизированные экстрактом килайи, и способы их приготовления
RU2012134605A (ru) Способ получения пищевой добавки
TH1701005258A (th) วิธีการสำหรับผลิตกรดฟูแรน-2,5-ไดคาร์บอกซิลิค (fdca) จากสารละลายเกลือ
TH1701005257A (th) วิธีการสำหรับผลิตกรดฟูแรน-2,5-ไดคาร์บอกซิลิค (fdca) จากเกลือของแข็ง
CA2872488A1 (en) Dehydrated castor oil as an animal feed supplement
TH168845A (th) สารองค์ประกอบไขน้ำมันสำหรับแป้งนวดของจำพวกเส้นบะหมี่และไขน้ำมันสำหรับ แป้งนวดของจำพวกเส้นบะหมี่และวิธีผลิตจำพวกเส้นบะหมี่
TH160005B (th) เชื้อเพลิงดีเซลเติมสารอิมัลซิไฟเออร์ที่มีค่าซีเทนสูง โดยมีกรดไขมันอิสระเป็นองค์ประกอบหลัก
PH12017502402A1 (en) Palm oil-based wax composition, encaustic medium derived therefrom and method for producing the same

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner